David Baxley Spetzler
President · Caris Life Sciences, Inc.
- 2025
- Sep 4, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Baxley Spetzler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian J. Brille - $12.13M in CAI purchases and sales in the last 12 months
- Jon Halbert - $990K in CAI purchases and sales in the last 12 months
- Jeff L. Vacirca - $501K in CAI purchases and sales in the last 12 months
- John Russel Denton - $339K in CAI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Baxley Spetzler?
David Baxley Spetzler is a corporate insider, tracked as President of Caris Life Sciences, Inc. (CAI). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Baxley Spetzler submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has David Baxley Spetzler been buying or selling stock?
Recorded transactions: 1 open-market purchase ($10K) and 3 open-market sales ($14.83M) across all tracked filings.
